TABLE 4.
Participant Characteristics by MRI Liver Steatosis Grade
| Variable | Median (IQR) or n (%) | |||
|---|---|---|---|---|
| ≤5% Steatosis (n = 23) | 5–33% Steatosis (n = 64) | 34–66% Steatosis (n = 19) | >66% Steatosis (n = 14) | |
| Age, years | 63 (61–67.24) | 61.16 (56.80–65.64) | 64.36 (55.16–68.27) | 59.07 (50.61–61.85) |
| Sex Male Female |
18 (78.3) 5 (21.70) |
36 (56.3) 28 (43.8) |
13 (68.4) 6 (31.6) |
7 (50) 7 (50) |
| Duration of diabetes, years | 12 (6–19) | 10 (5–17) | 8 (3–10) | 8 (1.75–10.5) |
| BMI, kg/m2 | 26.6 (25–30.80) | 30.9 (27.87–34.77) | 31 (28.75–32) | 33 (29.24–38.65) |
| Waist circumference, cm Male Female |
95 (90–109.25) 95 (82.5–103) |
109.5 (98–115.5) 102 (96–107–25) |
111 (103–121) 97 (96–100.25) |
120 (108–127) 103 (100–104) |
| Systolic blood pressure, mmHg | 120 (110–130) | 130 (120–130) | 125 (120–130) | 120 (120–130) |
| Diastolic blood pressure, mmHg | 65 (60–70) | 60 (60–70) | 60 (60–80) | 60 (58.75–70) |
| A1C, % | 6.6 (6.20–7.23) | 6.6 (6.2–7.3) | 6.8 (6.3–7.3) | 6.79 (6.24–6.93) |
| Glucose, mg/dL | 122 (108.75–147.75) | 121 (102.5–142.75) | 127 (106–144) | 128 (107.75–143.75) |
| AST, units/L | 17 (14–20) | 18 (15–23) | 20 (16–23) | 31 (21.75–40) |
| ALT, units/L | 14.5 (12–19.25) | 20 (17–29) | 24 (19–38) | 48.5 (32.5–70.75) |
| TSH, mg/dL | 1.57 (1.09–18.6) | 1.41 (10.7–2.19) | 1.2 (0.8–1.99) | 2 (1.12–2.77) |
| Total cholesterol, mg/dL | 147.5 (129.25–167.75) | 157 (136.25–174.5) | 153 (132–169) | 177.5 (126–189.5) |
| HDL cholesterol, mg/dL Male Female |
48 (37–53.75) 65 (50–75.5) |
41.5 (35.2–49) 51 (43.2–57.5) |
40 (35–49.5) 43 (38.75–55) |
41 (35–46) 44 (39–50) |
| LDL cholesterol, mg/dL | 85 (71–97) | 90.5 (76.5–108) | 82 (62–94) | 91.5 (63.5–114.25) |
| VLDL cholesterol, mg/dL | 21 (15–33) | 24 (18–32.75) | 24 (17–48) | 32.5 (19.7–41.5) |
| Triglycerides, mg/dL | 106 (74–127) | 116 (92.5–161.75) | 109 (97–193) | 141 (117.75–218) |
| SteatoTest grade S0 S0–S1 S1 S1–S2 S2 S2–S3 S3 |
8 (40) 6 (30) 2 (10) 1 (5) 2 (10) 0 (0) 0 (0) |
14 (22.2) 3 (4.8) 12 (19) 14 (22.2) 9 (14.3) 3 (4.8) 8 (12.7) |
2 (10.5) 4 (21.1) 2 (10.5) 4 (21.1) 2 (10.5) 1 (5.3) 4 (21.1) |
1 (7.1) 0 (0) 0 (0) 5 (35.7) 1 (7.1) 1 (7.1) 6 (42.9) |
| NashTest 2 grade N0 N1 N2 N3 |
8 (44.4) 5(27.8) 5 (27.8) 0 (0) |
9 (15.5) 29 (50) 18 (31) 2 (3.4) |
2 (11.8) 9 (52.9) 5 (29.4) 1 (5.9) |
0 (0) 5 (38.5) 5 (38.5) 3 (23.1) |
| ActiTest grade A0 A1 A2 A3 |
18 (78.3) 2 (8.7) 0 (0) 0 (0) |
53 (84.1) 8 (12.7) 0 (0) 2 (3.2) |
14 (73.7) 5 (26.3) 0 (0) 0 (0) |
4 (28.6) 9 (64.3) 1 (7.1) 0 (0) |
| FibroTest stage F0 F0–F1 F1 F1–F2 F2 F3 F3–F4 F4 |
5 (25) 5 (25) 2 (10) 8 (40) 0 (0) 0 (0) 0 (0) 0 (0) |
29 (46) 7 (11.1) 2 (3.2) 13 (20.6) 3 (4.8) 6 (9.5) 2 (3.2) 1 (1.6) |
7 (36.8) 2 (10.5) 3 (15.8) 3 (15.8) 0 (0) 3 (15.8) 0 (0) 1 (5.3) |
7 (50) 1 (7.1) 2 (14.3) 1 (7.1) 1 (7.1) 2 (14.3) 0 (0) 0 (0) |